TGF-β/BMP signaling and other molecular events: Regulation of osteoblastogenesis and bone formation

Bone Research

Volumn 3, Issue , 2015, Pages

  Rahman, Md Shaifur ^a   Akhtar, Naznin ^a   Jamil, Hossen Mohammad ^a   Banik, Rajat Suvra ^b   Asaduzzaman, Sikder M ^a  

^a INSTITUTE OF FOOD AND RADIATION BIOLOGY   (Bangladesh)

^b KHULNA UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934903660     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2015.5     Document Type: Review

References (182)

1. Beederman M, Lamplot JD, Nan G et al. BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng 2013; 6: 32-52.
2. Botchkarev VA. Bonemorphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol 2003; 120: 36-47.
3. Lechleider RJ, Ryan JL, Garrett L et al. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001; 240: 157-167.
4. Zhao GQ. Consequences of knocking out BMP signaling in the mouse. Genesis 2003; 35: 43-56.
5. Urist MR. Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 1997; 12: 343-346.
6. Carreira AC, Lojudice FH, Halcsik E, Navarro RD, Sogayar MC, Granjeiro JM. Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res 2014; 93: 335-345.
7. Feng XH, Derynck R. Specificity and versatility in TGF-b signaling through Smads. Annu Rev Cell Dev Biol 2005; 21: 659-693.
8. Balemans W, Hul WV. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002; 250: 231-250.
9. Moustakas A, Heldin CH. The regulation of TGF-b signal transduction. Development 2009; 136: 3699-3714.
10. Schmierer B, Hill CS. TGF-b-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8: 970-982.
11. Guo L, Zhao RC, Wu Y. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol 2011; 39: 608-616.
12. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008; 2: 1-13.
13. Pan A, Chang L, Nguyen A, James AW. A review of hedgehog signaling in cranial bone development. Front Physiol 2013; 4: 61.
14. Horikiri Y, Shimo T, Kurio N et al. Sonic hedgehog regulates osteoblast function by focal adhesion kinase signaling in the process of fracture healing. PLoS ONE 2013; 8: e76785.
15. Reichert JC, Schmalzl J, Prager P et al. Synergistic effect of Indian hedgehog and bone morphogenetic protein-2 gene transfer to increase the osteogenic potential of human mesenchymal stem cells. Stem Cell Res Ther 2013; 4: 105.
16. Kim JH, Liu X, Wang J et al. Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis 2013; 5: 13-31.
17. Issack PS, Helfet DL, Lane JM. Role of Wnt signaling in bone remodeling and repair. HSS J 2008; 4: 66-70.
18. Terada K, Misao S, Katase N, Nishimatsu S, Nohno T. Interaction of Wnt Signaling with BMP/Smad Signaling during the Transition from Cell Proliferation to Myogenic Differentiation in Mouse Myoblast-Derived Cells. Int J Cell Biol 2013; 2013: 616294.
19. Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation.J CellBiochem2011; 112: 3491-3501.
20. Balboni AL, Hutchinson JA, DeCastro AJ et al. DNp63a mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells. Cancer Res 2013; 73: 1020-1030.
21. Cheng H, Jiang W, Phillips FM et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-1552.
22. Kang Q, Sun, MH, Cheng H et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Therapy 2004; 11: 1312-1320.
23. Luther G, Wagner ER, Zhu G et al. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr Gene Ther 2011; 11: 229-240.
24. Lamplot JD, Qin J, Nan G et al. BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells 2013; 2: 1-21.
25. Rivera JC, Strohbach CA,Wenke JC, Rathbone CR. Beyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins. Front Pharmacol 2013; 4: 125.
26. Callis TE, Cao D, Wang DZ. Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circ Res 2005; 97: 992-1000.
27. Samartzis D, Khanna N, Shen FH, An HS. Update on bone morphogenetic proteins and their application in spine surgery. J Am Coll Surg 2005; 200: 236-248.
28. Gamer LW, Cox K, Carlo JM, Rosen V. Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev Dyn 2009; 238: 2374-2381.
29. Knö chel S, Dillinger K, Kö ster M, Knö chel W. Structure and expression of Xenopus tropicalis BMP-2 and BMP-4 genes. Mech Dev 2001; 109: 79-82.
30. Zuzarte-Luís V, Montero JA, Rodriguez-León J, Merino R, Rodríguez-Rey JC, Hurlé JM.A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev Biol 2004; 272: 39-52.
31. Paralkar VM, Grgurevic L, Simic P et al. A novel role of bone morphogenetic protein-6 (BMP-6) as an endocrine regulator of bone and glucose homeostasis. Bone 2010; 47: S57.
32. Tsumaki N, Yoshikawa H. The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 2005; 16: 279-285.
33. Lopez-Coviella I, Mellott TM, Kovacheva VP et al. Developmental pattern of expression of BMP receptors and Smads and activation of Smad1 and Smad5 by BMP9 in mouse basal forebrain. Brain Res 2006; 1088: 49-56.
34. Andersson O, Reissmann E, Ibanez CF. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep 2006; 7: 831-837.
35. Shen B, Bhargav D,Wei A et al. BMP-13 emerges as a potential inhibitor of bone formation. Int J Biol Sci 2009; 5: 192-200.
36. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004; 75: 106-111.
37. Nishimoto Y, Morisaki H, Yamada O, Ichinose Y, Suzuki N. Japanese case of hereditary hemorrhagic telangiectasia type 2 with a novel mutation, c.154A.C (p.Thr52Pro), in the ALK1/ACVRL1 gene. Neurol Clin Neurosci 2014; 2: 126-128.
38. Fukuda T, Kohda M, Kanomata K et al. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressive. J Biol Chem 2009; 284: 7149-7156.
39. Howe JR, Bair JL, Sayed MG et al. Germ line mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001; 28: 184-187.
40. Chen G, Deng C, Li YP. TGF-b and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272-288.
41. Fessel JP, Loyd JE, Austin ED. The genetics of pulmonary arterial hypertension in the post-BMPR2 era. Pulm Circ 2011; 1: 305-319.
42. Pearsall RS, Canalis E, Cornwall-Brady M et al. A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc Natl Acad Sci U S A 2008; 105: 7082-7087.
43. Goncalves MD. The role of the activin receptor type IIb (ActRIIB) in glucose and energy homeostasis. Dissertations available from ProQuest 2010; Paper AAI3447175. http://repository.upenn.edu/dissertations/AAI3447175.
44. Matsunobu T, Torigoe K, Ishikawa M et al. Critical roles of the TGF-b type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol 2009; 332: 325-338.
45. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147: 35-51.
46. Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 2010; 402: 186-189.
47. Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19: 2783-2810.
48. Estrada KD, Retting KN, Chin AM, Lyons KM. Smad6 is essential to limit BMP signaling during cartilage development. J Bone Miner Res 2011; 26: 2498-2510.
49. Song Q, Zhu B, HuWet al.Acommon SMAD7 variant is associated with risk of colorectal cancer: evidence from a case-control study and a metaanalysis. PLoS ONE 2012; 7: e33318.
50. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330.
51. Wu CJ, Lu HK. Smad signal pathway in BMP-2-induced osteogenesis a mini review. J Dent Sci 2008; 3: 13-21.
52. Inoue K, Ozaki S, Shiga T et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci 2002; 5: 946-954.
53. Constam DB, Robertson EJ. Regulation of bone morphogenetic protein activity by prodomains and proprotein convertases. J Cell Biol 1999; 144: 139-149.
54. Szpalski M, Gunzburg R. Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft? Acta Orthop Belg 2005; 71: 133-148.
55. Arrabal PM, Visser R, Santos-Ruiz L, Becerra J, CifuentesM. Osteogenic molecules for clinical applications: improving the BMP-collagen system. Biol Res 2013; 46: 421-429.
56. Granjeiro JM, Oliveira RC, Bustos-Valenzuela JC, Sogayar MC, Taga R. Bone morphogenetic proteins: from structure to clinical use. Braz J Med Biol Res 2005; 38: 1463-1473.
57. Rao SM, Ugale GM,Warad SB. Bonemorphogenetic proteins: periodontal regeneration. N Am J Med Sci 2013; 5: 161-168.
58. Muenster U, Korupolu R, Rastogi R, Read J, Fischer WH. Antagonism of activin by activin chimeras. Vitam Horm 2011; 85: 105-128.
59. Samad TA, Rebbapragada A, Bell E et al. DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem 2005; 280: 14122-14129.
60. Bonor J, Adams EL, Bragdon B, Moseychuk O, Czymmek KJ, Nohe A. Initiation of BMP2 signaling in domains on the plasma membrane. J Cell Physiol 2012; 227: 2880-2888.
61. Allendorph GP, Vale WW, Choe S. Structure of the ternary signaling complex of a TGF-beta superfamily member. Proc Natl Acad Sci U S A 2006; 103: 7643-7648.
62. Yu PB, Beppu H, Kawai N, Li E, Bloch KD. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J Biol Chem 2005; 280: 24443-24450.
63. Miyazono K, Maeda S, Imamur T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005; 16: 251-263.
64. Shore EM, Xu M, Feldman GJ et al.Arecurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressive. Nat Genet 2006; 38: 525-527.
65. Morovvati Z, SMorovvati S, Alishiri GA, Moosavi SH, Ranjbar R, Moghaddam YB. Mutation detection in activin A receptor, Type I (ACVR1) gene in fibrodysplasia ossificans progressiva in an Iranian family. Cell J 2014; 16: 91-94.
66. Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg Br 1975; 57: 36-45.
67. Kaplan FS, Le Merrer M, Glaser DL et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008; 22: 191-205.
68. Kaplan FS, Groppe J, Shore EM.When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov Today Ther Strateg 2008; 5: 255-262.
69. Yu PB, Deng DY, Lai CS et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 2008; 14: 1363-1369.
70. Gregson CL, Hollingworth P,WilliamsMet al.Anovel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date. Bone 2011; 48: 654-658.
71. Kaplan FS, Xu M, Seemann P et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 2009; 30: 379-390.
72. Petrie KA, Lee WH, Bullock AN et al. Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS ONE 2009; 4: e5005.
73. Ratbi I, Borcciadi R, Regragui A, Ravazzolo R, Sefiani A. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Clin Rheumatol 2010; 29: 119-121.
74. Carvalho DR, Navarro MM, Martins BJ et al. Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients. Clin Genet 2010; 77: 171-176.
75. Furuya H, Ikezoe K, Wang L et al. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 2008; 146A: 459-463.
76. Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R. Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 2009; 17: 311-318.
77. Chaikuad A, Alfano I, Kerr G et al. Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva. J Biol Chem 2012; 287: 36990-36998.
78. Bagarova J, Vonner AJ, Armstrong KA et al. Constitutively active ALK2 receptor mutants require Type II receptor cooperation. Mol Cell Biol 2013; 33: 2413-2424.
79. Lowery JW, Rosen V. Allele-specific RNA interference in FOP silencing the FOP gene. Gene Therapy 2012; 19: 701-702.
80. Wu JW,HuM, Chai J et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol Cell 2001; 8: 1277-1289.
81. Makkar P, Metpally RP, Sangadala S, Reddy BV. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif. J Mol Graph Model 2009; 27: 803-812.
82. ten Dijke P, Miyazono K, Heldin CH. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci 2000; 25: 64-70.
83. Zhang J, Fei T, Li Z, Zhu G, Wang L, Chen Y. BMP induces cochlin expression to facilitate self-renewal and suppress neural differentiation of mouse embryonic stem cells. J Biol Chem 2013; 288: 8053-8060.
84. Lo RS, Chen YG, Shi Y, Pavletich NP, Massague J. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. Embo J 1998; 17: 996-1005.
85. Liu F, Hata A, Baker JC et al. A human Mad protein acting as a BMPregulated transcriptional activator. Nature 1996; 381: 620-623.
86. Kusanagi K, Inoue H, Ishidou Y, Mishima HK, Kawabata M, Miyazono K. Characterization of a bone morphogenetic protein-responsive Smadbinding element. Mol Biol Cell 2000; 11: 555-565.
87. Mukhopadhyay P,Webb CL,Warner DR, Greene RM, Pisano MM. BMP signaling dynamics in embryonic orofacial tissue. J Cell Physiol 2008; 216: 771-779.
88. Morikawa M, Koinuma D, Tsutsumi S et al. ChIP-seq reveals cell typespecific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res 2011; 39: 8712-8727.
89. Ross S, Cheung E, Petrakis TG, Howell M, Kraus WL, Hill CS. Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J 2006; 25: 4490-4502.
90. James AW. Reviewof Signaling Pathways GoverningMSC Osteogenic and Adipogenic Differentiation. Scientifica (Cairo) 2013; 2013: 684736.
91. Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol 2006; 26: 6197-6208.
92. Edwards PC, Ruggiero S, Fantasia J et al. Sonic hedgehog gene-enhanced tissue engineering for bone regeneration. Gene Therapy 2005; 12: 75-86.
93. Karamboulas K, Dranse HJ, Underhill TM. Regulation of BMPdependent chondrogenesis in early limb mesenchyme by TGF beta signals. J Cell Sci 2010; 123: 2068-2076.
94. Yuasa T, Kataoka H, Kinto N et al. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J Cell Physiol 2002; 193: 225-232.
95. Deschaseaux F, Sensebe L, Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med 2009; 15: 417-429.
96. Zhang J, Tan X, LiWet al. Smad4 is required for the normal organization of the cartilage growth plate. Dev Biol 2005; 284: 311-322.
97. Kalderon D. Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol 2002; 12: 523-531.
98. Taipale J, Beachy PA. The Hedgehog and Wnt signaling pathways in cancer. Nature 2001; 411: 349-354.
99. Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis 2008; 4: 68-75.
100. Cadigan KM, Liu YI. Wnt signaling: complexity at the surface. J Cell Sci 2006; 119: 395-402.
101. Fuentealba LC, Eivers E, Ikeda A et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007; 131: 980-993.
102. Krishnan V, Bryant HU, MacDougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 2006; 116: 1202-1209.
103. Okamoto M, Udagawa N, Uehara S et al. Noncanonical Wnt5a enhances Wnt/b-catenin signaling during Osteoblastogenesis. Sci Rep 2014; 4: 4493.
104. Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. BMP-2 enhanced chondrogenesis involves p38 MAPK-mediated downregulation of Wnt-7a pathway. Mol Cells 2006; 22: 353-359.
105. Papathanasiou I, Malizos KN, Tsezou A. Bone morphogenetic protein-2-induced Wnt/b-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Arthritis Res Ther 2012; 14: R82.
106. Soltanoff CS, ChenW, Yang S, Li YP. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr 2009; 19: 1-46.
107. McCarthy TL, Centrella M. Novel links among Wnt and TGF-b signaling and Runx2. Mol Endocrinol 2010; 24: 587-597.
108. Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/b-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005; 8: 727-738.
109. Schramke V, Hairpin AR. RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 2003; 301: 1069-1074.
110. Lian JB, Stein GS, van Wijnen AJ et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012; 8: 212-227.
111. He X, Eberhart JK, Postlethwait JH. MicroRNAs and micromanaging the skeletonin disease, development and evolution. J Cell Mol Med 2009; 13: 606-618.
112. Jafferji M. Regulation of osteoblast differentiation by microRNAs. Umass Med School 2009; MQP-BIODSA-7214.
113. Li Z, Hassan MQ, Jafferji M et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284: 15676-15684.
114. Hu R, Liu W, Li H et al. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 2011; 286: 12328-12339.
115. Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 2010; 285: 25221-25231.
116. Zhang J, Tu Q, Bonewald LF et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically down regulating Wnt antagonist DKK1. J Bone Miner Res 2011; 26: 1953-1963.
117. Itoh T, Takeda S, Akao Y. MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene Homolog 1. J Biol Chem 2010; 285: 27745-27752.
118. Eskildsen T, TaipaleenmäkiH, Stenvang J et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci 2011; 108: 6139-6144.
119. Liu Y, Liu W, Hu C et al. MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem Cells 2011; 29: 1804-1816.
120. Mizoguchi F, Murakami Y, Saito T, Miyasaka N, Kohsaka H. MiR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther 2013; 15: R102.
121. Bae Y, Yang T, Zeng HC et al. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 2012; 21: 2991-3000.
122. Mizuno Y, Tokuzawa Y, Ninomiya Y et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 2009; 583: 2263-2268.
123. Mei Y, Bian C, Li J et al. miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem 2013; 114: 1374-1384.
124. Goff LA, Boucher S, Ricupero CL et al. Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol 2008; 36: 1354-1369.
125. Kim YJ, BaeSW, Yu SS, Bae YC, Jung JS. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 2009; 24: 816-825.
126. Schoolmeesters A, Eklund T, Leake D et al. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS ONE 2009; 4: e5605.
127. Kahai S, Lee SC, Lee DY et al. MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS ONE 2009; 4: e7535.
128. Oskowitz A, Lu J, Penfornis P et al. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A 2008; 105: 18372-18377.
129. Kuo PL, Liao SH, Hung JY, Huang MS, Hsu YL. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta 2013; 1830: 3756-3766.
130. Pollari S, Leivonen SK, Perälä M, Fey V, Käkönen SM, Kallioniemi O. Identification of microRNAs inhibiting TGF-b-induced IL-11 production in bone metastatic breast cancer cells. PLoS ONE 2012; 7: e37361.
131. Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK, Yu ZS. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. J Int Med Res 2012; 40: 859-866.
132. Tie J, Pan Y, Zhao L et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6: e1000879.
133. Octacílio-Silva S, Marques MM, Evangelista AF et al. Defining mRNA Targets of MicroRNAs during Osteoblastic Differentiation of Human Mesenchymal Stem Cells by Microarray Transcriptional Interaction Networks. Resumos do 566Congresso Brasileiro de Genética, Guarujá-SP, Brasil: 2010.
134. Valencia K, Martín-Fernandez M, Zandueta C et al. miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis. Bone 2013; 52: 532-539.
135. Hassan MQ, Gordon JA, Beloti MM et al. A network connecting Runx2, SATB2, and the miR-23a,27a,24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 2010; 107: 19879-19884.
136. Zeng Y, Qu X, Li H et al. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett 2012; 586: 2375-2381.
137. Vimalraj S, Selvamurugan N. MicroRNAs: Synthesis, gene regulation and osteoblast differentiation. Curr Issues Mol Biol 2012; 15: 7-18.
138. Inosea H, Ochi H, Kimura A et al. A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A 2009; 106: 20794-20799.
139. Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 2012; 72: 908-916.
140. Tomé M, López-Romero P, Albo C et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 2011; 18: 985-995.
141. Yin Q, Wang X, Fewell C et al. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol 2010; 84: 6318-6327.
142. Mizuno Y, Yagi K, Tokuzawa Y et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 2008; 368: 267-272.
143. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
144. Kretzschmar M, Doody J, Timokhina I, Massague J. A mechanism of repression of TGF beta/Smad signaling by oncogenic Ras. Genes Dev 1999; 13: 804-816.
145. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 2007; 25: 441-454.
146. Matsuura I,Wang G, He D, Liu F. Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry 2005; 44: 12546-12553.
147. Herpin A, Cunningham C. Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J 2007; 274: 2977-2985.
148. Leung-Hagesteijn C, Hu MC, Mahendra AS et al. Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis. Mol Cell Biol 2005; 25: 3648-3657.
149. Eivers E, Fuentealba LC,De Robertis EM. Integrating positional information at the level of Smad1/5/8. Curr Opin Genet Dev 2008; 18: 304-310.
150. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 2002; 277: 33361-33368.
151. Moustakas A, Heldin CH. Non-Smad TGF-beta signals. J Cell Sci 2005; 118: 3573-3584.
152. Engin F, Lee B. NOTCHing the bone: insights into multi-functionality. Bone 2010; 46: 274-280.
153. Tezuka K, Yasuda M, Watanabe N et al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 2002; 17: 231-239.
154. Turnpenny PD, Alman B, Cornier AS et al. Abnormal vertebral segmentation and the notch signaling pathway in man. Dev Dyn 2007; 236: 1456-1474.
155. Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 2014; 507: 376-380.
156. Luppen CA, Chandler RL, Noh T, Mortlock DP, Frenkel B. BMP-2 vs. BMP-4 expression and activity in glucocorticoid arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization. Growth Factors 2008; 26: 226-237.
157. Sheng N, Xie Z,Wang C et al. Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1. Proc Natl Acad SciUS A 2010; 107: 18886-18891.
158. McKeown SJ,Wallace AS, Anderson RB. Expression and function of cell adhesion molecules during neural crest migration. Dev Biol 2013; 373: 244-257.
159. Zhou J, Lee PL, Lee CI et al. BMP receptor-integrin interaction mediates responses of vascular endothelial Smad1/5 and proliferation to disturbed flow. J Thromb Haemost 2013; 11: 741-755.
160. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. TGF-binduced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 2012; 125: 1259-1273.
161. Xu J, Lamouille S, Derynck R. TGF-b induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172.
162. Song K,Wang H, Krebs TL, Danielpour D. Novel roles of Akt andmTOR in suppressing TGF-b/ALK5-mediated Smad3 activation. EMBO J 2006; 25: 58-69.
163. Dreieicher E, Beck KF, Lazaroski S et al. Nitric oxide inhibits glomerular TGF-b signaling via SMOC-1. J Am Soc Nephrol 2009; 20: 1963-1974.
164. Saura M, Zaragoza C, Herranz B et al. Nitric oxide regulates transforming growth factor-b signaling in endothelial Cells. Circ Res 2005; 97: 1115-1123.
165. Saito T, Fukai A, Mabuchi A et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 2010; 16: 678-686.
166. Mariani E, Pulsatelli L, Facchini A. Signaling pathways in cartilage repair. Int J Mol Sci 2014; 15: 8667-8698.
167. Sagar DR, Ashraf S, Xu L et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. Ann Rheum Dis 2014; 73: 1558-1565.
168. Nakashima T, Takayanagi H. The dynamic interplay between osteoclasts and the immune system. Arch Biochem Biophys 2008; 473: 166-171.
169. Jimi E, Hirata S, Shin M, Yamazaki M, Fukushima H. Molecular mechanisms of BMP-induced bone formation: cross-talk between BMP and NF-kB signaling pathways in osteoblastogenesis. Jpn Dent Sci Rev 2010; 46: 33-42.
170. Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H, Rosier RN. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NF-kB. Exp Cell Res 2006; 312: 40-50.
171. Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN. Endogenous TNFa lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kB. J Bone Miner Res 2007; 22: 646-655.
172. Kramer I, Halleux C, Feng JQ, Bonewald LF, Kneissel M. Osteocyte Wnt/b-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 2010; 30: 3071-3085.
173. Zhang Y, Khan D, Delling J, Tobiasch E. Mechanisms underlying the osteo and adipo differentiation of human mesenchymal stem cells. Sci World J 2012; 2012: 793823.
174. Das S, Samant RS, Shevde LA. The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer. Int J Breast Cancer 2012; 2012: 298623.
175. Hughes FJ, Turner W, G Belibasakis G, Martuscelli G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontol 2000 2006; 41: 48-72.
176. Fuller K, Lawrence KM, Ross JL et al. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. Bone 2008; 42: 200-211.
177. Xie H, Cui Z,Wang L et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 2014; 20: 1270-1278.
178. Gerstenfeld L, Edgar CM, Kakar S, Jacobsen KA, Einhorn TA. Osteogenic growth factors and cytokines and their role in bone repair engineering of functional skeletal tissues. Topics Bone Biol 2007; 3: 17-45.
179. Li X, Cao X. BMP signaling and skeletogenesis. Ann N Y Acad Sci 2006; 1068: 26-40.
180. Shimizu T, Tanaka T, Iso T et al. Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J Biol Chem 2011; 286: 19138-19148.
181. Sowa H, Kaji H, Hendy GN et al. Menin is required for bone morphogenetic protein 2-and transforming growth factor betaregulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 2004; 279: 40267-40275.
182. Li X, Cao X. BMP signaling and HOX transcription factors in limb development. Front Biosci 2003; 8: s805-s812.